Bluelinea SA
PAR:ALBLU

Watchlist Manager
Bluelinea SA Logo
Bluelinea SA
PAR:ALBLU
Watchlist
Price: 0.48 EUR 2.13%
Market Cap: 8.8m EUR

Wall Street
Price Targets

ALBLU Price Targets Summary
Bluelinea SA

There are no price targets for ALBLU.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bluelinea SA Competitors:
Price Targets
SRT
Sartorius AG
42% Upside
002901
Double Medical Technology Inc
8% Downside
BIOBV
Biohit Oyj
8% Upside
RMD
Resmed Inc
22% Upside
TMDX
Transmedics Group Inc
17% Upside
605186
Shanghai General Healthy Information and Technology Co Ltd
35% Upside
LIVN
LivaNova PLC
12% Upside
DCTH
Delcath Systems Inc
129% Upside

Revenue
Forecast

Revenue Estimate
Bluelinea SA

For the last 13 years the compound annual growth rate for Bluelinea SA's revenue is 26%. The projected CAGR for the next 5 years is -7%.

26%
Past Growth
-7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bluelinea SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bluelinea SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALBLU's stock price target?
Not Available

ALBLU doesn't have any price targets made by Wall Street professionals.

What is Bluelinea SA's Revenue forecast?
Projected CAGR
-7%

For the last 13 years the compound annual growth rate for Bluelinea SA's revenue is 26%. The projected CAGR for the next 5 years is -7%.

Back to Top